A decision aid for women at increased risk for ovarian cancer Tiller, K en_US Meiser, Bettina en_US Reeson, E en_US Tucker, Monica en_US Andrews, Leslie en_US Gaff, C en_US Kirk, J en_US Phillips, K en_US Friedlander, Michael en_US 2021-11-25T12:58:13Z 2021-11-25T12:58:13Z 2003 en_US
dc.description.abstract The use of chemotherapy and endocrine therapies in the treatment of pre-menopausal women carries with it reproductive and gynaecological implications which younger women may find both unpleasant and discordant with plans for childbearing. This study aims to investigate the fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. A retrospective qualitative methodology was chosen. Twenty-four women aged between 26 and 45 years at diagnosis participated in focus group interviews and telephone interviews. Many women thought that the information they had received in the past about fertility and menopausal symptoms was either insufficient or unavailable. Some women felt that, while information on fertility and menopause issues had not been paramount at the time of diagnosis, it became increasingly important after diagnosis. Participants spoke about the need to revisit or review fertility- and menopause-related information with their doctors during the course of treatment. Many women believed that information about fertility should be given prior to or during treatment decision-making, and that information related to the management of menopausal symptoms should be delivered during or after treatment when menopausal symptoms begin. Consultation with a fertility and/or menopause specialist-rated as the most preferred mode of receiving fertility- and menopause-related information. Clinical implications are drawn from the results of this study to assist clinicians and researchers to improve their communication with younger patients about the fertility- and menopause-related side effects of breast cancer treatment. en_US
dc.language English
dc.language.iso EN en_US
dc.rights CC BY-NC-ND 3.0 en_US
dc.rights.uri en_US
dc.source Legacy MARC en_US
dc.subject.other Ovarian cancer. en_US
dc.subject.other Women's health. en_US
dc.subject.other Gynaecology. en_US
dc.subject.other Chemotherapy. en_US
dc.subject.other Decision aid. en_US
dc.subject.other Cancer treatment. en_US
dc.title A decision aid for women at increased risk for ovarian cancer en_US
dc.type Journal Article en
dcterms.accessRights metadata only access
dspace.entity.type Publication en_US
unsw.identifier.doiPublisher en_US
unsw.relation.faculty Medicine & Health
unsw.relation.ispartofjournal International Journal of Gynaecological Cancer en_US
unsw.relation.ispartofpagefrompageto 15-22 en_US
unsw.relation.ispartofvolume 13 en_US
unsw.relation.originalPublicationAffiliation Tiller, K en_US
unsw.relation.originalPublicationAffiliation Meiser, Bettina, Prince of Wales Clinical School, Faculty of Medicine, UNSW en_US
unsw.relation.originalPublicationAffiliation Reeson, E en_US
unsw.relation.originalPublicationAffiliation Tucker, Monica en_US
unsw.relation.originalPublicationAffiliation Andrews, Leslie en_US
unsw.relation.originalPublicationAffiliation Gaff, C en_US
unsw.relation.originalPublicationAffiliation Kirk, J en_US
unsw.relation.originalPublicationAffiliation Phillips, K en_US
unsw.relation.originalPublicationAffiliation Friedlander, Michael, Prince of Wales Clinical School, Faculty of Medicine, UNSW en_US Clinical School Prince of Wales Hospital *
Resource type